Recognizing a something when your library sees it.
Advances are needed in random-display technologies to more tightly link drug actions and functions to the genes that control physiological processes. The reports discussed here explore two sides of these issues-generating new library formats and identifying the targets of drug ligands.
Fortin
Jean-Francois
JF
Department of Microbiology and Immunology, Baxter Laboratory of Genetic Pharmacology, Clinical Sciences Research Center, 269 Campus Drive, Stanford School of Medicine, Stanford, CA 94305, USA.
Nolan
Garry P
GP
D015195:Drug Design; D015698:Genomic Library; D019151:Peptide Library
D019151:Peptide Library